DIN 02230248 — LUPRON DEPOT 22.5 MG
LUPRON DEPOT is a powder for suspension (sustained-release of Leuprolide acetate marketed by ABBVIE CORPORATION. The full Leuprolide acetate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02230248
- Brand name
- LUPRON DEPOT
- Active ingredient
- Leuprolide acetate
- Strength
- 22.5 MG
- Dosage form
- POWDER FOR SUSPENSION (SUSTAINED-RELEASE
- Route
- INTRAMUSCULAR
- Manufacturer
- ABBVIE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Gonadotropin-releasing hormone (GnRH) agonist (LHRH analog)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Leuprolide acetate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02248240 | ELIGARD | 22.5 MG | POWDER FOR SUSPENSION (SUSTAINED-RELEASE | TOLMAR INTERNATIONAL LTD. | MARKETED |
| 02248999 | ELIGARD | 30 MG | POWDER FOR SUSPENSION (SUSTAINED-RELEASE | TOLMAR INTERNATIONAL LTD. | MARKETED |
| 02268892 | ELIGARD | 45 MG | POWDER FOR SUSPENSION (SUSTAINED-RELEASE | TOLMAR INTERNATIONAL LTD. | MARKETED |
| 02248239 | ELIGARD | 7.5 MG | POWDER FOR SUSPENSION (SUSTAINED-RELEASE | TOLMAR INTERNATIONAL LTD. | MARKETED |
| 02239834 | LUPRON DEPOT | 11.25 MG | POWDER FOR SUSPENSION (SUSTAINED-RELEASE | ABBVIE CORPORATION | MARKETED |
| 00884502 | LUPRON DEPOT | 3.75 MG | POWDER FOR SUSPENSION (SUSTAINED-RELEASE | ABBVIE CORPORATION | MARKETED |
| 02239833 | LUPRON DEPOT | 30 MG | POWDER FOR SUSPENSION (SUSTAINED-RELEASE | ABBVIE CORPORATION | MARKETED |
| 02562855 | LUPRON DEPOT | 45 MG | POWDER FOR SUSPENSION (SUSTAINED-RELEASE | ABBVIE CORPORATION | MARKETED |
| 00836273 | LUPRON DEPOT | 7.5 MG | POWDER FOR SUSPENSION (SUSTAINED-RELEASE | ABBVIE CORPORATION | MARKETED |
| 02462699 | ZEULIDE DEPOT | 22.5 MG | KIT; POWDER FOR SUSPENSION (SUSTAINED-RELEASE | VERITY PHARMACEUTICALS INC. | MARKETED |
| 02429977 | ZEULIDE DEPOT | 3.75 MG | KIT; POWDER FOR SUSPENSION (SUSTAINED-RELEASE | VERITY PHARMACEUTICALS INC. | MARKETED |